SmallCap
CompaniesStatistics

주식회사 타이로스코프(THYROSCOPE INC.)

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name주식회사 타이로스코프(THYROSCOPE INC.)
Business Reg. No.1468801720
CEO박재민
Address울산광역시 중구
Industry응용 소프트웨어 개발 및 공급업
Industry Code58222
Main Products모바일 의료용 소프트웨어
EstablishedContact
Phone052-264-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.230111-*******

Investment Metrics


Market Cap
-
Op. Margin
-27,627.2%
ROE
-47.81%
Debt Ratio
59.5%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2020-08-06 ~ 2022-08-05202001103492020-08-06
벤처투자유형2022-08-06 ~ 2025-08-05202208170100082020-08-06
벤처투자유형2025-08-06 ~ 2028-08-05202507300100172020-08-06

Financial Statements


3-Year Financial Data

Revenue CAGR +9.1%

Item202420232022
Revenue

0.1B

0.1B

0.0B

Operating Profit

-33.2B

-20.5B

-10.8B

Net Profit

-16.4B

-11.7B

-4.6B

Total Assets

54.7B

28.4B

11.7B

Total Liabilities

20.4B

17.7B

10.0B

Total Equity

34.3B

10.7B

1.6B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
120010K

118.2%

vs. 3-Year Avg.: 55010K
Operating Profit
-33B

111.4%

vs. 3-Year Avg.: -16B
Op. Margin
-27627.2%

48.0%

vs. 3-Year Avg.: -18666.4%
Debt Ratio
59.5%

84.7%

vs. 3-Year Avg.: 389.2%
ROE
-47.8%

75.4%

vs. 3-Year Avg.: -194.2%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
박재민대표이사대표

Employment Status


Regular EmployeesContact
CEO박재민

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "울산광역시 중구",
  "ceo_name": "박재민",
  "certificate": [
    {
      "cert_number": "20200110349",
      "changes": "",
      "disclosure_date": "2020-08-06",
      "first_cert_date": "2020-08-06",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-08-06 ~ 2022-08-05"
    },
    {
      "cert_number": "20220817010008",
      "changes": "",
      "disclosure_date": "2022-08-17",
      "first_cert_date": "2020-08-06",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-08-06 ~ 2025-08-05"
    },
    {
      "cert_number": "20250730010017",
      "changes": "",
      "disclosure_date": "2025-07-30",
      "first_cert_date": "2020-08-06",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-08-06 ~ 2028-08-05"
    }
  ],
  "company_name": "주식회사 타이로스코프(THYROSCOPE INC.)",
  "corp_no": "230111-*******",
  "financials": {
    "2022": {
      "capital_stock": 23638000,
      "cost_of_sales": 0,
      "current_assets": 586856000,
      "current_liabilities": 1003916000,
      "gross_profit": 0,
      "net_income": -456696000,
      "net_income_bs": -456696000,
      "non_current_assets": 580638000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 17757000,
      "non_operating_income": 644401000,
      "operating_profit": -1083340000,
      "revenue": 0,
      "sga_expenses": 1083340000,
      "total_assets": 1167494000,
      "total_equity": 163578000,
      "total_liabilities": 1003916000
    },
    "2023": {
      "capital_stock": 26988000,
      "cost_of_sales": 0,
      "current_assets": 1586849000,
      "current_liabilities": 996724000,
      "gross_profit": 11000000,
      "net_income": -1171624000,
      "net_income_bs": -1171624000,
      "non_current_assets": 1253715000,
      "non_current_liabilities": 770306000,
      "non_operating_expenses": 118527000,
      "non_operating_income": 1000211000,
      "operating_profit": -2053308000,
      "revenue": 11000000,
      "sga_expenses": 2064308000,
      "total_assets": 2840564000,
      "total_equity": 1073534000,
      "total_liabilities": 1767030000
    },
    "2024": {
      "capital_stock": 32985000,
      "cost_of_sales": 0,
      "current_assets": 3741538000,
      "current_liabilities": 1121650000,
      "gross_profit": 12000000,
      "net_income": -1641170000,
      "net_income_bs": -1641170000,
      "non_current_assets": 1733050000,
      "non_current_liabilities": 920555000,
      "non_operating_expenses": 97734000,
      "non_operating_income": 1771834000,
      "operating_profit": -3315270000,
      "revenue": 12000000,
      "sga_expenses": 3327270000,
      "total_assets": 5474588000,
      "total_equity": 3432383000,
      "total_liabilities": 2042205000
    }
  },
  "industry": "응용 소프트웨어 개발 및 공급업",
  "investment": [
    {
      "amount": "1,000,054,818",
      "changes": "1,000,054,818",
      "date": "2024-08-16"
    },
    {
      "amount": "199,000,000",
      "changes": "199,000,000",
      "date": "2021-12-24"
    },
    {
      "amount": "100,000,000",
      "changes": "100,000,000",
      "date": "2021-04-21"
    },
    {
      "amount": "51,000,000",
      "changes": "51,000,000",
      "date": "2020-10-06"
    }
  ],
  "main_products": "모바일 의료용 소프트웨어",
  "phone": "052-264-****",
  "years": [
    2024,
    2023,
    2022
  ]
}